MedPath

Transradial Intervention for Acute Coronary Syndrome -J-PCI Registry

Not Applicable
Conditions
Acute coronary syndrome
Registration Number
JPRN-UMIN000024576
Lead Sponsor
Tokai University
Brief Summary

Propensity score matching (PS) and instrumental variable (IV) analyses were used to account for treatment selection. The incidence of post-treatment adverse events was lower in the TRI group by 0.95% compared to the TFI group with PS (p < 0.001) and by 0.34% with IV (p = 0.127). A significantly lower risk for access site bleeding was observed by 0.34% with PS (p < 0.001) and by 0.53% with IV (p < 0.001).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
76835
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a composite of in-hospital death, MI associated with PCI, bleeding complication requiring transfusion, and stent thrombosis during in-hospital stay.
Secondary Outcome Measures
NameTimeMethod
Bleeding complications In hospital mortality
© Copyright 2025. All Rights Reserved by MedPath